RiverPark Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
RiverPark Advisors's LLY Position: Q1 2026 in Review
RiverPark Advisors increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $38.5K and bringing the position to 3,471 shares worth $3.19M. The position accounts for 1.16% of the portfolio, ranked #24.
RiverPark Advisors first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.69M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- RiverPark Advisors held 3,471 shares of Eli Lilly worth $3.19M as of Q1 2026.
- RiverPark Advisors bought 38 Eli Lilly shares in Q1 2026, an estimated $38.5K.
- Eli Lilly made up 1.16% of RiverPark Advisors's portfolio in Q1 2026, its #24 holding.
- RiverPark Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
- RiverPark Advisors's Eli Lilly position peaked at $3.69M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on RiverPark Advisors's 13F filing for Q1 2026, filed 14 May 2026.